Nivolumab Ipilimumab Combination Outperforms Tyrosine Kinase Inhibitors in Unresectable Hepatocellular Carcinoma
Patients with unresectable hepatocellular carcinoma reported better results with nivolumab ipilimumab. ...
Renal Cell Carcinoma
Authoritative medical articles, news, research, and guidelines pertaining to Renal Cell Carcinoma.
RELEVANT ARTICLES IN Renal Cell Carcinoma
Advertisement
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Meeting COVERAGE
PODCAST
Advertisement
MORE STORIES IN Renal Cell Carcinoma
Advertisement
PODCAST
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.